The Vox Markets Podcast

Q&A with Oncimmune CEO, Martin Gouldstone

loading...

January 31, 2025 11:21am

9m

Watch on YouTube

After this morning's trading update, CEO Martin Gouldstone of Oncimmune - a leading life sciences firm providing autoantibody profiling services to the Biopharma industry – takes me through the company's current demand picture, pipeline and August FY25 guidance.